13,464 HealthEquity, Inc. $HQY Shares Sold by Summit Creek Advisors LLC

Key Points

• Summit Creek Advisors cut its HealthEquity stake by 16%, selling 13,464 shares and ending the quarter with 70,693 shares valued at about $6.25 million.
• Institutional investors own 99.55% of HealthEquity shares. Analysts have a consensus “Moderate Buy” rating and an average price target of $113.53.
• HealthEquity beat quarterly estimates, reporting EPS of $1.24 versus $1.19 expected and revenue of $350.73 million, up 95.5% year over year.

Summit Creek Advisors LLC lowered its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 16.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 70,693 shares of the company's stock after selling 13,464 shares during the quarter. HealthEquity accounts for about 2.5% of Summit Creek Advisors LLC's investment portfolio, making the stock its 11th largest position. Summit Creek Advisors LLC owned approximately 0.09% of HealthEquity worth $6,254,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HQY. BlackRock Inc. bought a new stake in shares of HealthEquity during the 2nd quarter valued at $1,018,621,000. Wasatch Advisors LP lifted its stake in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company's stock valued at $719,014,000 after buying an additional 757,801 shares in the last quarter. William Blair Investment Management LLC bought a new position in HealthEquity in the 2nd quarter worth $160,158,000. Dimensional Fund Advisors LP boosted its holdings in HealthEquity by 2.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company's stock worth $135,957,000 after buying an additional 45,287 shares during the period. Finally, Bank of America Corp DE bought a new position in HealthEquity in the 2nd quarter worth $103,573,000. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. BTIG Research reiterated a "buy" rating and issued a $115.00 price target on shares of HealthEquity in a research note on Friday, August 28th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $135.00 to $142.00 and gave the company a "buy" rating in a research report on Monday, August 31st. Telsey Advisory Group set a $111.00 price objective on HealthEquity in a research report on Friday, August 28th. Weiss Ratings raised HealthEquity from a "buy (b-)" rating to a "buy (b)" rating in a research note on Monday, November 2nd. Finally, Barclays increased their target price on HealthEquity from $110.00 to $115.00 and gave the stock an "overweight" rating in a research report on Friday, September 18th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $113.53.

HealthEquity Trading Up 0.2%

HealthEquity stock opened at $103.63 on Friday. The stock has a market cap of $8.57 billion, a P/E ratio of 37.41, a PEG ratio of 1.64 and a beta of 0.22. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $110.26. The firm's 50 day moving average price is $95.52 and its 200-day moving average price is $89.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The firm had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. The company's revenue for the quarter was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, equities analysts predict that HealthEquity, Inc. will post 3.94 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of HealthEquity stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director directly owned 62,395 shares in the company, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.60% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits.

Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Founded in 2002, HealthEquity is based in Draper, Utah, and serves customers across the United States.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.